Whalesbook
E-Pharmacies Grow While Traditional Stores Struggle
The proposed nationwide strike by the AIOCD, meant as a united front against online pharmacies, has instead revealed a fractured traditional pharmacy sector. This suggests the idea of a united traditional front against online pharmacies is no longer holding. It highlights changing market forces, where e-pharmacies use regulatory gaps and efficient operations to grow their market share, while the government tries to balance new technology with patient safety.
The Indian e-pharmacy market is expected to grow significantly, potentially reaching about $3.4 billion by 2030, growing 18-20% annually. Companies like Tata 1mg, Apollo 24/7, PharmEasy, and Netmeds are quickly gaining market share. Tata 1mg led with an estimated 31% share, followed by Apollo 24/7 at 28%. PharmEasy, despite substantial revenue, faced major financial challenges, with its parent company's valuation dropping 92% from its peak. Apollo Hospitals' pharmacy business, however, shows strong revenue growth and profits, projecting around Rs 25,000 crore by FY27.
This digital surge contrasts with the challenges facing traditional chemists. Independent pharmacies, making up about 54% of the market, often struggle with low profits, high costs, and limited reach, especially in rural areas. Fragmented distribution networks lead to inefficiencies and higher costs than the direct sales model used by e-pharmacies.
Regulatory Gaps Fuel Conflict
The AIOCD's protest focuses on alleged regulatory loopholes used by e-pharmacies, referencing notifications like GSR 817(E) and GSR 220(E). The AIOCD claims these allow for insufficient prescription verification, potentially enabling the uncontrolled sale of antibiotics and addictive medicines. The use of AI-generated fake prescriptions adds to these concerns, creating a major public health risk.
Draft rules for e-pharmacies proposed in 2018 are still not finalized, leaving a regulatory gap. The Central Drugs Standard Control Organisation (CDSCO) is reportedly looking into these issues, but the absence of clear, comprehensive rules creates unfair competition.
Key Risks in a Fragmented Market
The current dispute highlights several weaknesses that could disadvantage traditional chemists and create broader risks.
Fragmented Opposition: The refusal of many state-level pharmacy associations and major chains to join the AIOCD strike shows a lack of a common strategy within the traditional sector. This allows e-pharmacies to move faster with less organized pushback.
Growing Antibiotic Resistance: Uncontrolled antibiotic sales due to weak checks are a major concern. India already has a serious problem with antibiotic resistance, and the misuse of antibiotics, possibly increased by AI-generated prescriptions, could worsen antibiotic resistance, leading to serious public health issues and higher death rates.
Exploiting Regulatory Gaps: The ongoing delay in finalizing e-pharmacy regulations allows online platforms to operate in a regulatory grey zone, possibly using temporary or draft rules to their benefit while traditional pharmacies follow older, stricter rules.
Inefficient Supply Chains: The traditional multi-tiered distribution system is less efficient than the direct sales model used by e-pharmacies, leading to higher costs and slower delivery, especially outside major cities.
Risk of Counterfeit Drugs: Current regulatory gaps and AI's ability to create fake documents increase the risk of counterfeit and low-quality medicines entering the supply chain, threatening patient safety.
The Path Forward: Digital Health Changes
The government is focused on dialogue and ensuring people can always get medicines, especially vulnerable patients. However, its review of the sector's rules suggests changes are coming. The outcome of this regulatory review, alongside the shift towards digital options, will determine future competition. The different interests between traditional sellers and fast-moving e-pharmacies, plus worries about drug safety and public health, mean India's drug distribution sector is at a key point, likely facing more changes and consolidation.